28035426|t|Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
28035426|a|INTRODUCTION: The characteristics of dementia with Lewy bodies (DLB), Alzheimer's disease (AD) and amnestic mild cognitive impairment (a-MCI) overlap but require different treatments; therefore, it is important to differentiate these pathologies. Assessment of dopamine uptake in the striatum using dopamine transporter (DaT) single-photon emission computed tomography (SPECT) is the gold standard for diagnosing DLB; however, this modality is expensive, time consuming and involves radiation exposure. Degeneration of the substantia nigra nigrosome-1, which occurs in DLB, but not in AD/a-MCI, can be identified by 3T susceptibility-weighted imaging (SWI). Therefore, the aim of this retrospective observational study was to compare SWI with DaT-SPECT for differentiation of DLB from AD/a-MCI. METHODS: SWI data were acquired for patients with clinically diagnosed DLB (n = 29), AD (n = 18), a-MCI (n = 13) and healthy controls (n = 26). Images were analysed for nigrosome-1 degeneration. Diagnostic accuracy was evaluated for DLB, AD and a-MCI compared with striatal dopamine uptake using DaT-SPECT. RESULTS: SWI achieved 90% diagnostic accuracy (93% sensitivity, 87% specificity) for the detection of nigrosome-1 degeneration in DLB and not in AD/a-MCI as compared with 88.3% accuracy (93% sensitivity, 84% specificity) using DaT-SPECT. CONCLUSIONS: SWI nigrosome-1 evaluation was useful in differentiating DLB from AD/a-MCI, with high accuracy. This less invasive and less expensive method is a potential alternative to DaT-SPECT for the diagnosis of DLB.
28035426	22	47	dementia with Lewy bodies	Disease	MESH:D020961
28035426	113	133	dopamine transporter	Gene	6531
28035426	252	277	dementia with Lewy bodies	Disease	MESH:D020961
28035426	279	282	DLB	Disease	MESH:D020961
28035426	285	304	Alzheimer's disease	Disease	MESH:D000544
28035426	306	308	AD	Disease	MESH:D000544
28035426	314	348	amnestic mild cognitive impairment	Disease	MESH:D060825
28035426	350	355	a-MCI	Disease	MESH:D060825
28035426	476	484	dopamine	Chemical	MESH:D004298
28035426	514	534	dopamine transporter	Gene	6531
28035426	536	539	DaT	Gene	6531
28035426	628	631	DLB	Disease	MESH:D020961
28035426	731	764	of the substantia nigra nigrosome	Disease	MESH:C000656904
28035426	784	787	DLB	Disease	MESH:D020961
28035426	800	802	AD	Disease	MESH:D000544
28035426	803	808	a-MCI	Disease	MESH:D060825
28035426	958	961	DaT	Gene	6531
28035426	991	994	DLB	Disease	MESH:D020961
28035426	1000	1002	AD	Disease	MESH:D000544
28035426	1003	1008	a-MCI	Disease	MESH:D060825
28035426	1046	1054	patients	Species	9606
28035426	1081	1084	DLB	Disease	MESH:D020961
28035426	1095	1097	AD	Disease	MESH:D000544
28035426	1108	1113	a-MCI	Disease	MESH:D060825
28035426	1179	1203	nigrosome-1 degeneration	Disease	MESH:D009410
28035426	1243	1246	DLB	Disease	MESH:D020961
28035426	1248	1250	AD	Disease	MESH:D000544
28035426	1255	1260	a-MCI	Disease	MESH:D060825
28035426	1284	1292	dopamine	Chemical	MESH:D004298
28035426	1306	1309	DaT	Gene	6531
28035426	1419	1443	nigrosome-1 degeneration	Disease	MESH:D009410
28035426	1447	1450	DLB	Disease	MESH:D020961
28035426	1462	1464	AD	Disease	MESH:D000544
28035426	1465	1470	a-MCI	Disease	MESH:D060825
28035426	1544	1547	DaT	Gene	6531
28035426	1625	1628	DLB	Disease	MESH:D020961
28035426	1634	1636	AD	Disease	MESH:D000544
28035426	1637	1642	a-MCI	Disease	MESH:D060825
28035426	1739	1742	DaT	Gene	6531
28035426	1770	1773	DLB	Disease	MESH:D020961
28035426	Association	MESH:D020961	6531
28035426	Association	MESH:D004298	MESH:D060825
28035426	Association	MESH:D004298	6531
28035426	Association	MESH:D004298	MESH:D020961

